News
New Award: Congratulations Benjamin Matthews, M.D.!
TITLE: PR1P, an inhaled novel short peptide for Acute Lung Injury and ARDS. TYPE OF AWARD: Drive TECHNOLOGY TYPE: Small Molecule CLINICAL AREA: Lung INSTITUTION: Boston Children’s Hospital DESCRIPTION:ARDS is an acute inflammatory lung disease characterized by hypoxemia and multi-organ failure with mortality reaching 50%. It accounts for almost 200,000 ICU admissions yearly in the US and…
Read MoreVenture Adventure: Exploring the Role of the Inventor in Commercialization
Written by Carl Berke, PhD. Partner at the Partners Innovation Fund Thomas Edison famously remarked, “Invention is 1% inspiration and 99% perspiration”. The Wizard of Menlo Park was a prolific inventor who never left his lab, but his intellectual property was adopted by a plethora of companies who translated his technology into products that delighted…
Read MoreSpecialist Series: Understanding And Articulating Your Financials And Funding Requirements
By Lesley Watts When describing the financial support necessary to develop a technology, the first step is to be clear about the scope of the work you are addressing, as no single source of funding will be able to support all of the associated R&D costs. Anyone who is assessing your project plan will want…
Read MoreSuccess Stories: B-BIC’s Work With Platelet Biogenesis
WATCH: B-BIC’s Work With Platelet Biogenesis One of B-BIC’s first grant recipients was Jonathan Thon, a researcher based at Brigham and Women’s Hospital. Jonathan and his team had been researching two technologies necessary for producing platelets outside of the body. They had achieved promising results that demonstrated a microfluidic platform could simulate bone marrow physiological…
Read MoreFAST PITCH FOR FUNDING: What we are looking for when awarding B-BIC partnerships
Potential for commercialization. Technology that addresses an unmet clinical need. Heart, Lung, Blood or Sleep indications. Preliminary data indicating promise of commercialization. Differentiation from competitors. IP filings, with institutions as the assignee. OUR NEXT FAST PITCH FOR FUNDING is Wednesday, January 30, 2019 from 10am – 12pm at NORTHEASTERN UNIVERSITY, 360 Huntington Ave, McLeod Suites, in the…
Read MoreFAST PITCH FOR FUNDING: Quick Tips for a successful pitch
Keep pitch short and focused on the technology and its commercial application. Limit the discussion of preliminary results, and focus on the most relevant results with conclusions – not data. Present the science within the context of the business strategy. OUR NEXT FAST PITCH FOR FUNDING is Wednesday, January 30, 2019 from 10am – 12pm at NORTHEASTERN UNIVERSITY,…
Read MoreNEW AWARD: CONGRATULATIONS DR J. BRIAN MCALVIN
RECIPIENT: Dr. J. Brian McAlvin TITLE: A Novel Method To Treat The Systemic Inflammatory Response Syndrome (SIRS) TYPE OF AWARD: Pilot TECHNOLOGY TYPE: Therapeutic Device CLINICAL AREA: Blood INSTITUTION: Boston Children’s Hospital DESCRIPTION: We have developed highly-selective blood-filtering devices that are capable of filtering of individual, harmful molecules from the blood of patients rendered critically ill by the…
Read MoreTips & Tricks: Explaining Your Proposed Solution
Understand the population you are targeting and why. It may be preferable to define a narrower niche for your entry to the market. Consider where your device/drug will be administered and by what means. This choice will greatly influence the preclinical and clinical development needs and strategies. Most investors will want to see proof-of-concept (POC)…
Read MoreNEW AWARD: CONGRATULATIONS, DR. SYLVIE BRETON!
RECIPIENT: Dr. Sylvie Breton TITLE: Predicting and Preventing Acute Kidney Injury Associated with Cardiovascular Diseases TYPE OF AWARD: PILOT TECHNOLOGY TYPE: Small Molecule Drug CLINICAL AREA: Heart INDICATION: Acute Kidney Injury INSTITUTION: MGH DESCRIPTION: Acute kidney injury (AKI) is a frequent complication of hospitalized patients. Unfortunately, there is no cure for this potentially deadly condition. Thus, a critical…
Read MoreNIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges
Commercializing innovations in academic environments is notoriously challenging. Here, we describe the progress of the NIH Centers for Accelerated Innovations program — initiated in 2013 to address these challenges — which we believe could help set a new standard for the early-stage commercialization of biomedical innovations in academic environments. Read More On Nature.com.
Read More